NEWS

Ingenuity Systems extends software agreement with GlaxoSmithKline

Ingenuity Systems has extended and expanded its existing license agreement with GlaxoSmithKline for access to Ingenuity Pathways Analysis (IPA) software. 

 

The new agreement enables GSK to provide enterprise-wide IPA access to researchers for rapid assessment of the signalling and metabolic pathways, molecular networks, and biological processes that are most significant to disease targets.  In addition, GSK will also use Ingenuity's content and proprietary algorithms.

 

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Analysis and opinion
Feature

Robert Roe looks at research from the University of Alaska that is using HPC to change the way we look at the movement of ice sheets

Feature

Robert Roe talks to cooling experts to find out what innovation lies ahead for HPC users

Analysis and opinion